← Home / IDEAYA Biosciences, Inc. (IDYA)
Stock Analysis
IDEAYA Biosciences, Inc. (IDYA)
IDYA
IDYA · Market data
36.01 +0.00%
Track IDYA in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IDYA price is:
52W Range Position
76%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-20 18:48 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 40.51. Holding above 33.71 keeps the current thesis intact.
⚖️
✓
Fundamentals
Weak / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
33.71
↗
Break Above
Confirmation improves above resistance.
40.51
🎯
Next Objective
Pattern-derived target if setup continues.
37.09
×
Thesis Break
Scenario weakens below invalidation.
Below 33.71
What's Driving IDYA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 40.51 for confirmation and 33.71 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 33.71 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
54.3
Price Chart
IDYA · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-17
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$3.2B
Company size
EV
$3.0B
Debt-adjusted value
P/E
-22.6
Not meaningful
P/S
13.6
Premium
P/B
3.4
Balanced
EV/Sales
12.9
Premium
EV/EBIT
-16.4
Not meaningful
P/FCF
-36.0
Not meaningful
FCF Yield
-2.78%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
6.56M
↘ Weak
📈 Net Income
-98.54M
↘ Negative
🧮 EPS (Basic)
-1.11
↘ Negative
IDEAYA Biosciences, Inc.
Related Opportunities